0001883850-22-000072.txt : 20221003 0001883850-22-000072.hdr.sgml : 20221003 20221003160544 ACCESSION NUMBER: 0001883850-22-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220929 FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tessier-Lavigne Marc CENTRAL INDEX KEY: 0001437435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 221287523 MAIL ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-09-29 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001437435 Tessier-Lavigne Marc 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2022-09-29 4 M 0 3798 413.33 A 6067 D Common Stock 2022-09-29 4 S 0 16 686.89 D 6051 D Common Stock 2022-09-29 4 S 0 321 687.9 D 5730 D Common Stock 2022-09-29 4 S 0 637 688.71 D 5093 D Common Stock 2022-09-29 4 S 0 1009 689.56 D 4084 D Common Stock 2022-09-29 4 S 0 692 690.65 D 3392 D Common Stock 2022-09-29 4 S 0 554 691.59 D 2838 D Common Stock 2022-09-29 4 S 0 85 696.13 D 2753 D Common Stock 2022-09-29 4 S 0 160 697.29 D 2593 D Common Stock 2022-09-29 4 S 0 208 698.44 D 2385 D Common Stock 2022-09-29 4 S 0 80 699.82 D 2305 D Common Stock 2022-09-29 4 S 0 16 702.36 D 2289 D Common Stock 2022-09-29 4 S 0 20 704.83 D 2269 D Common Stock 2022-09-30 4 M 0 3428 413.33 A 5697 D Common Stock 2022-09-30 4 S 0 3428 698.0 D 2269 D Common Stock 2022-10-03 4 M 0 3612 413.33 A 5881 D Common Stock 2022-10-03 4 S 0 3612 718.0 D 2269 D Non-Qualified Stock Option (right to buy) 413.33 2022-09-29 4 M 0 3798 0.0 D 2025-01-02 Common Stock 3798 7040 D Non-Qualified Stock Option (right to buy) 413.33 2022-09-30 4 M 0 3428 0.0 D 2025-01-02 Common Stock 3428 3612 D Non-Qualified Stock Option (right to buy) 413.33 2022-10-03 4 M 0 3612 0.0 D 2025-01-02 Common Stock 3612 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 16 shares of Company stock on September 29, 2022 at prices ranging from $686.89 to $686.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. Represents volume-weighted average price of sales of 321 shares of Company stock on September 29, 2022 at prices ranging from $687.05 to $687.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. Represents volume-weighted average price of sales of 637 shares of Company stock on September 29, 2022 at prices ranging from $688.08 to $688.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. Represents volume-weighted average price of sales of 1,009 shares of Company stock on September 29, 2022 at prices ranging from $689.07 to $689.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. Represents volume-weighted average price of sales of 692 shares of Company stock on September 29, 2022 at prices ranging from $690.06 to $690.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. Represents volume-weighted average price of sales of 554 shares of Company stock on September 29, 2022 at prices ranging from $691.29 to $691.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. Represents volume-weighted average price of sales of 85 shares of Company stock on September 29, 2022 at prices ranging from $696.03 to $696.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. Represents volume-weighted average price of sales of 160 shares of Company stock on September 29, 2022 at prices ranging from $697.10 to $697.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. Represents volume-weighted average price of sales of 208 shares of Company stock on September 29, 2022 at prices ranging from $698.19 to $698.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Marc Tessier-Lavigne 2022-10-03